Author:
Uren Roger F.,Nieweg Omgo E.,Thompson John F.
Publisher
Springer International Publishing
Reference89 articles.
1. Alazraki NP, Eshima D, Eshima LA, Herda SC, Murray DR, Vansant JP, Taylor AT (1997) Lymphoscintigraphy, the sentinel node concept, and the intraoperative gamma probe in melanoma, breast cancer, and other potential cancers. Semin Nucl Med 27(1):55–67
2. Belhocine TZ, Scott AM, Even-Sapir E, Urbain JL, Essner R, Belhocine TZ, Scott AM, Even-Sapir E, Urbain J-L, Essner R (2006) Role of nuclear medicine in the management of cutaneous malignant melanoma. J Nucl Med 47(6):957–967
3. Bergqvist L, Strand SE, Persson BR (1983) Particle sizing and biokinetics of interstitial lymphoscintigraphic agents. Semin Nucl Med 13(1):9–19
4. Bergqvist L, Strand SE, Hafstrom L, Jonsson PE (1984) Lymphoscintigraphy in patients with malignant melanoma: a quantitative and qualitative evaluation of its usefulness. Eur J Nucl Med 9(3):129–135
5. Bouchot O, Bouvier S, Bochereau G, Jeddi M (1993) Cancer of the penis: the value of systematic biopsy of the superficial inguinal lymph nodes in clinical N0 stage patients. Prog Urol 3(2):228–233